Acute pain trials start with assumptions. How you execute—when reality sets in—determines the outcome.
When you’re designing an acute pain clinical trial, it’s perfectly normal to have some early assumptions in mind during the planning process, such as how sites will operate, how patients will behave, and how the data will come together to tell your overall story.
But trials don’t run in controlled conditions, so those assumptions get tested very quickly.
In acute pain, that is especially clear.
Any gap between your assumptions and reality can directly shape your outcomes, so you must be ready to act if it does—and it will. Here are some common assumptions we’ve seen in acute pain trials, along with what actually happens when reality is added to the equation.
Pain expertise is great, but it’s pain execution that really counts.
“If the protocol looks good, the evidence will come together easily.”
You build a great study on paper, but even strong designs are susceptible to small shifts when patient, site, and clinical realities come into play. Because of the fast-paced nature of acute pain clinical trials, it’s easy to get caught in a cycle of playing catch-up. Assessment windows are short, leaving teams susceptible to missed or mistimed data points and inconsistent data. Once data is missing or compromised, you can’t just recreate it later during the analysis. The path to interpretable evidence is often less predictable than expected, so your coordination and execution are even more critical in acute pain studies.
“Fast enrollment is a win-win-win.”
While we all dream of fast enrollment, that speed can sometimes add complexity and create downstream pressure. Your source data verification, data cleaning, and database lock timelines all get sped up, which can cause panic—especially if you have to escalate the issue through layers of organizational hierarchy to reach the one decision-maker. What you need are teams who are aligned across functions that can respond in real time. That means coordinating clinical operations, data management, project delivery, and other critical functions to protect your execution quality—and, in turn, protect data integrity and timeline commitments without disruption.
“Acute pain trials are easier because the timeline is short.”
Actually, the short timeline is exactly what makes acute pain clinical trials particularly unforgiving. They move fast, rely on subjective endpoints, and don’t allow for recovery from early mistakes. Usually, these trials don’t fail because of bad science; they fail in execution. Instead of waiting for something to go wrong, it’s safer to assume that something will go wrong. So, with little margin for error, teams can’t let small issues turn into bigger “pain” points—they must act quickly (and with quality) to address them.
“If rescue medication is requested early, then our protocol is broken.”
Your original plans and models forecast that rescue medication will be used within a certain period. However, you can’t really predict how humans will react in the moment (especially when they’re struggling with intense acute pain symptoms). The good news: This doesn’t mean you are experiencing a protocol failure. In fact, quite the opposite. What it really means is that patients might start behaving exactly like humans in pain behave, and investigators then respond to their patients’ needs. Keep in mind that these realities have other effects on your study, including your timing-sensitive endpoints. But if you recognize the emerging dynamics, you can always reassess your early assumptions before moving forward.
“Since we’re using experienced sites, variability risk shouldn’t be a concern.”
Even great sites operate in their own unique way. Small differences from one site to another may not be dramatic on their own, but they can gradually accumulate and introduce more variability. By recognizing regional differences and becoming more aware, teams can plan for and detect variability earlier (and more effectively). No matter how many studies a site has conducted, it’s always crucial to make sure your teams coordinate with them to make things run as easily as possible. That’s achieved by really showing up for them, communicating clearly, and proactively supporting them when issues come up. In turn, those actions translate into better trust and long-term partnerships.
“Historical precedent keeps the program predictable—and that’s what we want.”
Precedent feels like a logical way to reduce uncertainty in your program, but it is only useful when it informs judgment. It’s easy to default to familiar frameworks because they’ve worked before. At the same time, they can shape your overall story…and not always in a good way. For example, endpoint choices that rely too heavily on history make true clinical benefit harder to demonstrate. A therapy may be effective and provide real relief for patients; however, if it isn’t aligned with your measurement framework, it can limit what your data can show—and set you back. Over time, leaning too heavily on precedent creates a disconnect between patient experience, how it’s measured, and the story the data ultimately tells.
The best acute pain programs plan for success, while also planning for how the real-world will influence the work. Because once your study begins to scale, you’re guaranteed to experience small shifts that will test your early assumptions. It takes more than one single expert to get the job done. Having a CRO partner who truly works together under pressure can make or break your acute pain trial—and at Rho, we have led sponsors to success time and again.
Download our acute pain clinical trial guide so you can prepare for the realities of acute pain trials and execute them with confidence. A more resilient acute pain study begins with the right awareness—and then having the ability to act on it.